Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 September 2021 | Story Nonsindiso Qwabe
“This way please” UFS Clinic nurses point the way. From left to right: Sister Nangamso Lukhubeni, Sister Noluthando Luthuli, Sister Mathapelo Moloi, and Sister Modiehi Moloi.

Fully vaccinated! 

These were the words uttered by many Qwaqwa staff members who received their second Pfizer jab at the vaccination site on the Qwaqwa Campus on Thursday (2 September 2021). More than 100 staff members turned up at the site, many for the second jab, while others were there to get their first. The staff members were full of praise for the convenience of having a site on campus, and said the brisk service made the entire process a breeze. The 24/7 Study Centre on campus was repurposed as a vaccination site at the end of August, bringing much-needed relief to staff and students, as well as the Qwaqwa community.

The vaccination experience

Chelly König, Professional Officer in the Department of Chemistry, urged people to trust the science behind the vaccine and the fact that it works. König also came with her relatives. “I’m fully vaccinated and feeling fantastic. I’d urge anyone who’s still hesitant to trust the sciences; these people know what they are doing. My aunt, who is 62, developed COVID-19 after getting her two jabs, and she didn’t experience any effects at all. It was just like the flu. Seeing her recovery convinced me that the vaccine works.”

Ntswaki Mokoena of Bidvest Prestige Cleaning Services also received her second jab. She said: “I am fully vaccinated and so happy. I’ve experienced no side effects whatsoever, and I encourage people to vaccinate; the vaccine is harmless. They should not listen to naysayers who haven’t even vaccinated.”

Calling on more people to vaccinate 

Sister Mathapelo Moloi, Chief Officer at the campus clinic, said the vaccination drive was a source of pride for the campus. “Our priority is to re-open the campus, so I’m very happy that we are seeing staff and students being willing to get vaccinated.”

“It’s not the first time that there has been hesitancy around the vaccine. Providing information is our priority – to help them understand the side effects and everything pertaining to the vaccine.”

Acting Director of Student Affairs on Qwaqwa Campus, Zakhele Mdluli, said vaccinations would help the university community get back to normal. “I encourage students to get vaccinated so that they are able to come back to campus knowing that everyone is safe. This vaccination is no different from the vaccinations we used to get when we were younger.”

The centre operates Monday to Friday from 08:00 to 15:00. People can pre-register either online at https://vaccine.enroll.health.gov.za or via WhatsApp on +27 0 60 012 3456 and should bring along their identity documents. The site is open to anyone 18 years and older. They can simply walk in – no bookings are required.”

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept